Although pentoxifylline and cilostazol may provide symptomatic relief, the management of IC must address the underlying problem of PVD. Resolution of risk factors, such as smoking, diabetes, ...
Cilostazol exhibits its pharmacologic effects via antiplatelet, vasodilatory, and antithrombotic activities. Like pentoxifylline, cilostazol and several of its metabolites exhibit these antiplatelet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results